Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)
Editas Medicine (EDIT) reported Other Operating Expenses of $2000.0 for Q4 2020, up 100.0% year-over-year from $1000.0 in Q1 2020, and up 100.0% quarter-over-quarter from $1000.0 in Q4 2019.
Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020) Analysis & Trends
Editas Medicine (EDIT) has 4 years of Other Operating Expenses data on file, last reported at $2000.0 in Q4 2020.
- Other Operating Expenses for Q4 2020 came in at $2000.0, up 100.0% year-over-year; the trailing twelve-month figure through Sep 2021 was $2000.0 (up 100.0% YoY), and the FY2016 annual result was $40.5 million, changed N/A from the prior year.
- Other Operating Expenses rose to $2000.0 in Q4 2020 per EDIT's latest filing, from $1000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $40.1 million in Q4 2017 and troughed at $1000.0 in Q4 2019.
- A 4-year average of $12.6 million and a median of $5.2 million in 2016 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2017 and 2020: Other Operating Expenses soared 288.09% in 2017, then jumped 100.0% in 2020.
- A 4-year view of Other Operating Expenses shows it stood at $10.3 million in 2016, then soared by 288.09% to $40.1 million in 2017, then sank by 100.0% to $1000.0 in 2019, then jumped by 100.0% to $2000.0 in 2020.
- Business Quant data shows EDIT's Other Operating Expenses at $2000.0 in Q4 2020, $1000.0 in Q4 2019, and $40.1 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2017 | 40.11 Mn |
| Dec 31, 2016 | 10.34 Mn |